Bystolic Generic Name & Formulations
Legal Class
General Description
Pharmacological Class
How Supplied
Manufacturer
Generic Availability
NO
Mechanism of Action
Bystolic Indications
Indications
Bystolic Dosage and Administration
Adult
Children
Bystolic Contraindications
Contraindications
Bystolic Boxed Warnings
Not Applicable
Bystolic Warnings/Precautions
Warnings/Precautions
CHF. Angina. Recent MI. Bronchospastic disease. Increased risk for hypoglycemia esp. in diabetics or those who are fasting (eg, surgery, not eating regularly, or vomiting). Hyperthyroidism. Severe renal impairment. Moderate hepatic impairment. Avoid abrupt cessation (taper over 1–2 weeks). Surgery. Peripheral vascular disease. Pheochromocytoma. Neonates (monitor). Pregnancy (esp. during 3rd trimester). Nursing mothers: not recommended.
Bystolic Pharmacokinetics
Absorption
Mean peak plasma concentrations occur ~1.5–4 hours post-dosing.
Distribution
Plasma protein bound: ~98%.
Elimination
Renal (38%), fecal (44%). Half-life: ~12 hours.
Bystolic Interactions
Interactions
Bystolic Adverse Reactions
Adverse Reactions
Bystolic Clinical Trials
See Literature
Bystolic Note
Not Applicable
Bystolic Patient Counseling
See Literature
Images
